Loading provider…
Loading provider…
Infectious Disease Physician in Gainesville, FL
NPI: 1235158759Primary Practice Location
VA NORTH FLORIDA/SOUTH GEORGIA HEALTHCARE SYSTEM - GAINESVILLE
1601 Sw Archer Rd, Gainesville, FL
Primary Employer
Malcom Randall VA Medical Center
va.gov
HQ Phone
Get MD, PHD Gary's Phone Numberphone_androidMobile
Get MD, PHD Gary's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
PA State Medical License
FL State Medical License
2009 - 2027
PA State Medical License
2004 - 2010

American Board of Internal Medicine
Infectious Disease
Weill Cornell Medicine
weill.cornell.edu
B.A. • Chemistry
1990 - 1994
Lewis Katz School of Medicine
medicine.temple.edu
Medical School
Until 2001
University of Pennsylvania Health System
Fellowship • Infectious Disease
2004 - 2006
Yale-New Haven Medical Center
Residency • Internal Medicine
2001 - 2004
Temple University
Ph.D. • Biochemistry
1994 - 2001
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 23 | 26 |
| 2 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 19 | 19 |
| 3 | 99223Initial hospital inpatient care, typically 70 minutes per day | 17 | 18 |
| 4 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 14 | 23 |
Authors: Li, Hao, Christman, Lindsey M, Yagiz, Yavuz, Washington, Taylor L, Wang, Gary P, Gu, Liwei
Journal: Food Funct
Publication Date: 2024-03-18
Lead Sponsor: University of Florida
Intervention / Treatment: PROCEDURE: Phase II Optimal Frequency, PROCEDURE: Group 1 will receive 15 Hz, PROCEDURE: Group 2 will receive 30 Hz, PROCEDURE: Group 3 will receive 60 Hz, PROCEDURE: Group 4 will receive 100 Hz
Lead Sponsor: Actelion
Intervention / Treatment: DRUG: Vancomycin, DRUG: Cadazolid, DRUG: Cadazolid-matching placebo, DRUG: Vancomycin-matching placebo
Lead Sponsor: Rebiotix Inc.
Intervention / Treatment: BIOLOGICAL: RBX2660 (microbiota suspension)